VERA
Price
$22.65
Change
-$0.64 (-2.75%)
Updated
Jun 27 closing price
Capitalization
1.45B
40 days until earnings call
VYGR
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Jun 27 closing price
Capitalization
163.24M
33 days until earnings call
Interact to see
Advertisement

VERA vs VYGR

Header iconVERA vs VYGR Comparison
Open Charts VERA vs VYGRBanner chart's image
Vera Therapeutics
Price$22.65
Change-$0.64 (-2.75%)
Volume$2.68M
Capitalization1.45B
Voyager Therapeutics
Price$2.96
Change-$0.01 (-0.34%)
Volume$1.09M
Capitalization163.24M
VERA vs VYGR Comparison Chart in %
Loading...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VERA vs. VYGR commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VERA is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (VERA: $22.66 vs. VYGR: $2.95)
Brand notoriety: VERA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VERA: 121% vs. VYGR: 183%
Market capitalization -- VERA: $1.45B vs. VYGR: $163.24M
VERA [@Biotechnology] is valued at $1.45B. VYGR’s [@Biotechnology] market capitalization is $163.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VERA’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • VERA’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than VERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VERA’s TA Score shows that 2 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • VERA’s TA Score: 2 bullish, 7 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than VERA.

Price Growth

VERA (@Biotechnology) experienced а +8.63% price change this week, while VYGR (@Biotechnology) price change was -0.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

VERA is expected to report earnings on Aug 07, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.45B) has a higher market cap than VYGR($163M). VERA (-46.418) and VYGR (-47.972) have similar YTD gains . VYGR has higher annual earnings (EBITDA): -97.25M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. VYGR (236M). VYGR has less debt than VERA: VYGR (42M) vs VERA (54.5M). VYGR has higher revenues than VERA: VYGR (67M) vs VERA (0).
VERAVYGRVERA / VYGR
Capitalization1.45B163M887%
EBITDA-167.77M-97.25M173%
Gain YTD-46.418-47.97297%
P/E RatioN/A6.00-
Revenue067M-
Total Cash590M236M250%
Total Debt54.5M42M130%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VERAVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCGEX14.020.07
+0.50%
Calamos Global Equity C
FCNAX44.63N/A
N/A
Fidelity Advisor Consumer Discret A
HWTIX11.14N/A
N/A
Hotchkis & Wiley Intl Sm Cp Dvsfd Val I
JHQDX18.78N/A
N/A
JPMorgan Hedged Equity 2 I
FSSLX11.64N/A
N/A
Fidelity Series Small Cap Core

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.67%
RGNX - VYGR
52%
Loosely correlated
-4.11%
TRDA - VYGR
51%
Loosely correlated
-1.57%
KYMR - VYGR
51%
Loosely correlated
-3.48%
XNCR - VYGR
49%
Loosely correlated
-3.10%
IMNM - VYGR
48%
Loosely correlated
-0.11%
More